Additional Ventures support for single ventricle heart disease research
Aug 3 2020
The Loh and Rabinovitch laboratories received new support from Additional Ventures and the Stanford Maternal and Child Health Research Institute to study single-ventricle heart disease, using pluripotent stem cell technology.
